Botox Ain’t Scared

From a media Webinar: The Science Behind Botox: A 20-Year Perspective:

The good people who bring you The Real Housewives of NYC have a message for you, and no, I’m not talking about the Bravo network. (Although I have a message for them: KEEP IT COMING!)

I’m talking about the makers of Botox, of course, and the message they tried to convey in an hour-long media Webinar today was that Reloxin is coming, but we ain’t scared. (Or, scuuurrrred, for the young’uns out there.)

Ain't scared. From Flickr Creative Commons user Paul Stevenson

Ain't scared. From Flickr Creative Commons user Paul Stevenson

“We have a world share of around 83%” of the botulinum toxin market, said David Pyott, CEO of Allergan, the maker of Botox. “We’re outselling the competitors by about seven times. And in the hands of thousands of physicians across many countries around the world, faced with the data…physicians have made their choice. And that’s a very important fact for people to consider.”

Reloxin isn’t even approved in the U.S. yet, though it is expected soon. Makes you wonder, though: If the facts speak for themselves, why call this conference? Worried about losing some of that market share?

—Denise Napoli @Denisenapoli

Bookmark and Share

1 Comment

Filed under Dermatology

One response to “Botox Ain’t Scared

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s